Nasal Spray Live Attenuated Influenza Vaccine (LAIV) is a vaccine designed to protect individuals against the influenza virus. Unlike traditional injectable vaccines that contain inactivated virus particles, the LAIV uses a weakened, live version of the influenza virus. This live virus is attenuated, meaning it has been modified to significantly reduce its virulence while maintaining its ability to stimulate the immune system effectively. LAIV is typically administered through the nose, offering an alternative to injectable flu vaccines. FluMist is one of the most recognized brands in this category, gaining popularity due to its ease of use and non-invasive nature.
Market Size
The global Nasal Spray Live Attenuated Influenza Vaccine Market for Nasal Spray Live Attenuated Influenza Vaccine is poised for significant growth. As of 2024, the market size is estimated at USD 718.50 million, and it is projected to reach USD 1,216.18 million by 2032, growing at a CAGR of 6.80% during the forecast period.
This growth is attributed to the increasing adoption of LAIV, especially in countries with advanced healthcare infrastructure, rising awareness about the benefits of nasal vaccination, and growing initiatives from governments and health organizations to increase vaccination rates.
Regional Breakdown
-
North America: In 2024, the North American market was valued at USD 209.68 million and is expected to expand at a CAGR of 5.83% through 2032.
-
Europe: Europe is a prominent market for LAIV, with several countries offering the nasal spray vaccine as part of their national vaccination programs.
-
Asia-Pacific: The Asia-Pacific region is witnessing increasing awareness of immunization, with rapid urbanization and better access to healthcare services driving demand.
-
South America and Middle East & Africa: These regions are expected to see gradual growth as healthcare initiatives and vaccine accessibility improve.
Market Dynamics
Drivers
-
Increased Adoption of Non-Invasive Vaccines: With growing preference for non-injection-based vaccines, Nasal Spray LAIV offers a convenient alternative, boosting its adoption, especially among children and individuals with needle phobia.
-
Government Immunization Programs: Many governments are integrating nasal spray vaccines into their public health programs to reduce the incidence of seasonal flu.
-
Higher Efficacy: Studies suggest that live vaccines such as LAIV may offer better protection against flu strains, particularly in younger populations, which enhances their market potential.
-
Rising Awareness: Global awareness campaigns about flu prevention and vaccination contribute to the demand for LAIV.
Restraints
-
Limited Availability: While the vaccine is highly effective, its availability is sometimes limited in certain regions due to production and distribution challenges.
-
Cost: LAIV can be more expensive compared to traditional flu vaccines, which may limit its uptake in low-income regions.
-
Regulatory Challenges: Stringent regulatory requirements for the approval of live vaccines can delay market entry and expansion.
Opportunities
-
Expansion in Developing Markets: As vaccination awareness and healthcare access improve in developing regions, there is a huge opportunity for LAIV to penetrate untapped markets.
-
Advancements in Vaccine Technology: Innovation in nasal vaccine formulations, such as adding protection against more flu strains, presents opportunities for product expansion and differentiation.
-
Seasonal Vaccination Programs: The increasing importance of flu vaccinations during seasonal outbreaks presents a significant opportunity for expanding the market for LAIV.
Challenges
-
Concerns over Safety: While the vaccine is attenuated, the use of a live virus may raise safety concerns, especially in immunocompromised individuals, limiting its widespread adoption.
-
Competition from Injectable Vaccines: Traditional flu vaccines still dominate the market due to established safety records and lower costs.
-
Vaccine Hesitancy: Despite the benefits, some populations remain hesitant about receiving vaccines, including LAIV, due to misconceptions or misinformation.
Regional Analysis
The global market for Nasal Spray Live Attenuated Influenza Vaccine is expanding across all regions, but certain geographic areas are leading the charge due to their developed healthcare infrastructure and high vaccination rates.
-
North America: North America is the largest market for LAIV, driven by widespread acceptance of nasal vaccines, government initiatives, and a high level of healthcare awareness. The U.S. is the largest contributor to this growth, with programs like FluMist being heavily promoted.
-
Europe: Europe’s market is expanding due to strong healthcare systems and national vaccination programs that include nasal vaccines.
-
Asia-Pacific: Rapid urbanization and an increasing focus on public health are expected to fuel growth in the Asia-Pacific region, with countries like Japan and India adopting nasal spray vaccines more widely.
-
South America & MEA: The adoption of LAIV is expected to grow as access to healthcare improves and awareness about flu prevention increases.
Competitor Analysis
The competitive landscape of the Nasal Spray Live Attenuated Influenza Vaccine market includes several key players such as:
-
Sanofi Pasteur: A leading global player, Sanofi offers FluMist, a popular brand of LAIV.
-
AstraZeneca: Known for its contributions to the vaccine market, AstraZeneca continues to innovate in the LAIV space.
-
CSL: With a global presence, CSL is a significant contributor to the vaccine market, including the development and distribution of nasal spray vaccines.
-
Abbott: Abbott’s involvement in LAIV research and development has helped expand the availability of these vaccines.
-
GlaxoSmithKline: GSK plays a pivotal role in vaccine manufacturing and distribution, including for LAIV.
Global Nasal Spray Live Attenuated Influenza Vaccine: Market Segmentation Analysis
This report provides a deep insight into the global Nasal Spray Live Attenuated Influenza Vaccine market, covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trends, niche markets, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader shape the competition within the industries and strategies for the competitive environment to enhance potential profit. Furthermore, it provides a simple framework for evaluating and assessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nasal Spray Live Attenuated Influenza Vaccine Market, introducing in detail the market share, market performance, product situation, and operational situation of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nasal Spray Live Attenuated Influenza Vaccine market.
Market Segmentation (by Application)
-
Hospital
-
Clinic
-
Public Health Agency
-
Others
Market Segmentation (by Type)
-
Trivalent Flu Vaccine
-
Quadrivalent Flu Vaccine
Key Company
Geographic Segmentation
-
North America (USA, Canada, Mexico)
-
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
-
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
-
South America (Brazil, Argentina, Columbia, Rest of South America)
-
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
FAQ Section
What is the current market size of the Nasal Spray Live Attenuated Influenza Vaccine market?
Which are the key companies operating in the Nasal Spray Live Attenuated Influenza Vaccine market?
-
Key companies include Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, and Serum Institute.
What are the key growth drivers in the Nasal Spray Live Attenuated Influenza Vaccine market?
-
Key drivers include increased adoption of non-invasive vaccines, government immunization programs, higher efficacy, and rising awareness about flu prevention.
Which regions dominate the Nasal Spray Live Attenuated Influenza Vaccine market?
-
North America, particularly the USA, dominates the market, followed by Europe and the Asia-Pacific region.
What are the emerging trends in the Nasal Spray Live Attenuated Influenza Vaccine market?
Key Benefits of This Market Research:
-
Industry drivers, restraints, and opportunities covered in the study
-
Neutral perspective on the market performance
-
Recent industry trends and developments
-
Competitive landscape & strategies of key players
-
Potential & niche segments and regions exhibiting promising growth covered
-
Historical, current, and projected market size, in terms of value
-
In-depth analysis of the Nasal Spray Live Attenuated Influenza Vaccine Market
-
Overview of the regional outlook of the Nasal Spray Live Attenuated Influenza Vaccine Market:
Key Reasons to Buy this Report:
-
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
-
This enables you to anticipate market changes to remain ahead of your competitors
-
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
-
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
-
Provision of market value data for each segment and sub-segment
-
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
-
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
-
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
-
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
-
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
-
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nasal Spray Live Attenuated Influenza Vaccine
1.2 Key Market Segments
1.2.1 Nasal Spray Live Attenuated Influenza Vaccine Segment by Type
1.2.2 Nasal Spray Live Attenuated Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nasal Spray Live Attenuated Influenza Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nasal Spray Live Attenuated Influenza Vaccine Market Competitive Landscape
3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Nasal Spray Live Attenuated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Sales Sites, Area Served, Product Type
3.6 Nasal Spray Live Attenuated Influenza Vaccine Market Competitive Situation and Trends
3.6.1 Nasal Spray Live Attenuated Influenza Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nasal Spray Live Attenuated Influenza Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nasal Spray Live Attenuated Influenza Vaccine Industry Chain Analysis
4.1 Nasal Spray Live Attenuated Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nasal Spray Live Attenuated Influenza Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nasal Spray Live Attenuated Influenza Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Nasal Spray Live Attenuated Influenza Vaccine Price by Type (2019-2025)
7 Nasal Spray Live Attenuated Influenza Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nasal Spray Live Attenuated Influenza Vaccine Market Sales by Application (2019-2025)
7.3 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Growth Rate by Application (2019-2025)
8 Nasal Spray Live Attenuated Influenza Vaccine Market Consumption by Region
8.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region
8.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region
8.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Nasal Spray Live Attenuated Influenza Vaccine Market Production by Region
9.1 Global Production of Nasal Spray Live Attenuated Influenza Vaccine by Region (2019-2025)
9.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Nasal Spray Live Attenuated Influenza Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Nasal Spray Live Attenuated Influenza Vaccine Production
9.4.1 North America Nasal Spray Live Attenuated Influenza Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Nasal Spray Live Attenuated Influenza Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Production
9.5.1 Europe Nasal Spray Live Attenuated Influenza Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Nasal Spray Live Attenuated Influenza Vaccine Production (2019-2025)
9.6.1 Japan Nasal Spray Live Attenuated Influenza Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Nasal Spray Live Attenuated Influenza Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Nasal Spray Live Attenuated Influenza Vaccine Production (2019-2025)
9.7.1 China Nasal Spray Live Attenuated Influenza Vaccine Production Growth Rate (2019-2025)
9.7.2 China Nasal Spray Live Attenuated Influenza Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.1.2 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.1.4 Sanofi Pasteur Business Overview
10.1.5 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine SWOT Analysis
10.1.6 Sanofi Pasteur Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.2.2 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 CSL
10.3.1 CSL Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.3.2 CSL Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.3.4 CSL Nasal Spray Live Attenuated Influenza Vaccine SWOT Analysis
10.3.5 CSL Business Overview
10.3.6 CSL Recent Developments
10.4 Abbott
10.4.1 Abbott Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.4.2 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.4.4 Abbott Business Overview
10.4.5 Abbott Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.5.2 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.5.4 GlaxoSmithKline Business Overview
10.5.5 GlaxoSmithKline Recent Developments
10.6 Serum Institute
10.6.1 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.6.2 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.6.4 Serum Institute Business Overview
10.6.5 Serum Institute Recent Developments
10.7 Fluenz Tetra
10.7.1 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.7.2 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.7.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.7.4 Fluenz Tetra Business Overview
10.7.5 Fluenz Tetra Recent Developments
10.8 BioDiem
10.8.1 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.8.2 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.8.4 BioDiem Business Overview
10.8.5 BioDiem Recent Developments
10.9 FluMist
10.9.1 FluMist Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.9.2 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.9.4 FluMist Business Overview
10.9.5 FluMist Recent Developments
10.10 ChangChun High and New Technology
10.10.1 ChangChun High and New Technology Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.10.2 ChangChun High and New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.10.3 ChangChun High and New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.10.4 ChangChun High and New Technology Business Overview
10.10.5 ChangChun High and New Technology Recent Developments
10.11 BCHT Biotechnology
10.11.1 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Basic Information
10.11.2 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Overview
10.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Market Performance
10.11.4 BCHT Biotechnology Business Overview
10.11.5 BCHT Biotechnology Recent Developments
11 Nasal Spray Live Attenuated Influenza Vaccine Market Forecast by Region
11.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast
11.2 Global Nasal Spray Live Attenuated Influenza Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Region
11.2.4 South America Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Nasal Spray Live Attenuated Influenza Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Nasal Spray Live Attenuated Influenza Vaccine by Type (2025-2032)
12.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Nasal Spray Live Attenuated Influenza Vaccine by Type (2025-2032)
12.2 Global Nasal Spray Live Attenuated Influenza Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nasal Spray Live Attenuated Influenza Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Live Attenuated Influenza Vaccine as of 2022)
Table 10. Global Market Nasal Spray Live Attenuated Influenza Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Sales Sites and Area Served
Table 12. Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Product Type
Table 13. Global Nasal Spray Live Attenuated Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nasal Spray Live Attenuated Influenza Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nasal Spray Live Attenuated Influenza Vaccine Market Challenges
Table 22. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (K MT)
Table 23. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size by Type (M USD)
Table 24. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Nasal Spray Live Attenuated Influenza Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) by Application
Table 30. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size by Application
Table 31. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Application (2019-2025)
Table 35. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Nasal Spray Live Attenuated Influenza Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Nasal Spray Live Attenuated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Nasal Spray Live Attenuated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Nasal Spray Live Attenuated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Nasal Spray Live Attenuated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Nasal Spray Live Attenuated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 52. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 53. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Sanofi Pasteur Business Overview
Table 55. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine SWOT Analysis
Table 56. Sanofi Pasteur Recent Developments
Table 57. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 58. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 59. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine SWOT Analysis
Table 62. AstraZeneca Recent Developments
Table 63. CSL Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 64. CSL Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 65. CSL Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. CSL Nasal Spray Live Attenuated Influenza Vaccine SWOT Analysis
Table 67. CSL Business Overview
Table 68. CSL Recent Developments
Table 69. Abbott Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 70. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 71. Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Abbott Business Overview
Table 73. Abbott Recent Developments
Table 74. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 75. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 76. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Recent Developments
Table 79. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 80. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 81. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Serum Institute Business Overview
Table 83. Serum Institute Recent Developments
Table 84. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 85. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 86. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Fluenz Tetra Business Overview
Table 88. Fluenz Tetra Recent Developments
Table 89. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 90. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 91. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. BioDiem Business Overview
Table 93. BioDiem Recent Developments
Table 94. FluMist Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 95. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 96. FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. FluMist Business Overview
Table 98. FluMist Recent Developments
Table 99. ChangChun High and New Technology Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 100. ChangChun High and New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 101. ChangChun High and New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. ChangChun High and New Technology Business Overview
Table 103. ChangChun High and New Technology Recent Developments
Table 104. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Basic Information
Table 105. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Overview
Table 106. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. BCHT Biotechnology Business Overview
Table 108. BCHT Biotechnology Recent Developments
Table 109. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Nasal Spray Live Attenuated Influenza Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Nasal Spray Live Attenuated Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country (M USD)
Figure 11. Nasal Spray Live Attenuated Influenza Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Nasal Spray Live Attenuated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nasal Spray Live Attenuated Influenza Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nasal Spray Live Attenuated Influenza Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Type
Figure 18. Sales Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Type in 2023
Figure 20. Market Size Share of Nasal Spray Live Attenuated Influenza Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Application
Figure 24. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application in 2023
Figure 26. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Application (2019-2025)
Figure 27. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Application in 2023
Figure 28. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Nasal Spray Live Attenuated Influenza Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Nasal Spray Live Attenuated Influenza Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region in 2023
Figure 44. China Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Nasal Spray Live Attenuated Influenza Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Nasal Spray Live Attenuated Influenza Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Nasal Spray Live Attenuated Influenza Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Nasal Spray Live Attenuated Influenza Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Nasal Spray Live Attenuated Influenza Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Nasal Spray Live Attenuated Influenza Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share Forecast by Application (2025-2032)
